3.0
7 Sept 2017
Former employee, more than 5 years
São Paulo, São Paulo
Recommend
CEO approval
Business outlook
Pros
Renowed biotech with good portfolio and pipeline. Opportunities to grow in career, developing people is an strenght, global marketing team is very differentiated.
Cons
Upper management with little understanding of value and access. Few people with broad experience in specialized market as oncology and hematology.